Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study

Immunization; Infection Clinical Trial

— MOPING  

Official title:

EFFICACY OF MOBILE PHONE REMINDERS (AND PHOTOVOICE) IN IMPROVING CHILDHOOD IMMUNIZATION UPTAKE AND REDUCING INCIDENCE OF VACCINE-PREVENTABLE DISEASES - A RANDOMIZED CONTROLLED TRIAL AMONG POSTPARTUM MOTHERS AND CAREGIVERS IN NIGERIA

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03402646
• Other study ID #: MOPING/V2/07/17
• Status: Not yet recruiting
• Phase: N/A
• First received: December 19, 2017
• Last updated: January 10, 2018
• Start date: May 2018
• Est. completion date: December 2019

Study information

• Verified date: January 2018
• Source: Universiti Putra Malaysia
• Contact: Surajudeen A Abdulrahman, MBBS, PhD
• Phone: +60167067760
• Email: abdulsuraj[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to implement and test the efficacy of photovoice, Short Messaging Service (SMS) and phone call reminders in improving childhood immunization coverage (uptake, timeliness and completion rates) and reducing incidence of vaccine-preventable diseases (VPDs) among infants in Nigeria

Description:

This will be a single-blind three-arm cluster randomized controlled trial involving post-partum mothers and/or caregivers of infants (age 0-12months) attending immunization clinics in 12 randomly selected Primary Health Care Centres (clusters) across Sokoto, Jigawa, Kano, Ogun, Oyo and Lagos States of Nigeria. Additionally, a photovoice methodology will be implemented in 6 community clusters (one in each State) involving group discussions between community members (pregnant women in their third trimester, parents/caregivers of infants age 0-12 months), community leaders, service providers and policy makers on benefits of timely immunization and consequences of non-vaccination. Parent-infant pairs will be followed up for 12 months during which SMS and phone call immunization clinic appointment reminders will be provided to mothers and/or caregivers in intervention arm 1, and photovoice intervention provided at study commencement to participants in intervention arm 2. Respondents in the control group would receive standard care (routine paper-based appointment scheduling alone). The investigators will document and compare immunization uptake (all doses and vaccines), timeliness of receipt and completion rates of scheduled immunization between the three groups, as well as incidence of VPDs between the groups using multivariate statistical analyses.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1813
• Est. completion date: December 2019
• Est. primary completion date: June 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Mothers/caregivers of healthy infants (age 0 - 12 months) who:

1. Have a mobile phone access

2. Received antenatal care and/or delivered their babies in a hospital

3. Plans to receive immunizations at the selected PHCs

• Purposively-selected community sample of pregnant women in their third trimester, parents/caregivers of infants, providers, community gatekeepers and policy makers

Exclusion Criteria:

1. Parents of infants requiring hospital admission due to significant illness, congenital deformity/malformation and prematurity

2. Foreigners

Related Conditions & MeSH terms

• Immunization; Infection

Intervention

Behavioral:
• Reminder module (SMS and Phone call)
Same as described under arm/group descriptions
• Photovoice
Same as described under arm/group descriptions

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Universiti Putra Malaysia	Penang Medical College

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Immunization coverage	Proportion of randomized infants who received birth doses of BCG and OPV (overall), and complete doses of each vaccine as scheduled	12 months
Primary	Timeliness of receipt of scheduled immunization	Proportion of infants receiving scheduled immunization within 1 week of schedule	12 months
Secondary	Incidence of any childhood vaccine-preventable disease	Risk ratio of vaccine-preventable disease between intervention and control groups	12 months